An Ophthalmic Formulation of a Beta-Adrenoceptor Antagonist,Levobetaxolol,Using Poly(Acrylic Acid) Nanoparticles as Carrier: Loading and Release Studies
Restricted accessResearch articleFirst published online January, 2001
An Ophthalmic Formulation of a Beta-Adrenoceptor Antagonist,Levobetaxolol,Using Poly(Acrylic Acid) Nanoparticles as Carrier: Loading and Release Studies
Poly(acrylic acid) (PAA) nanoparticles were synthesized by reverse microemulsion polymerization using an oil-soluble initiator. The particles had a narrow size range, ∼50 nm, and were stable in phosphate buffer. The particles were recovered and lyophilized in dry powder form and were redispersible in buffer. The drug levobetaxolol was loaded into the nanoparticles from aqueous drug solutions. When the drug-loaded particles were dispersed in a phosphate buffer solution the drug was released over several hours. The drug formulation in PAA nanoparticles was stable for more than 2 months at 4°C and at room temperature.
Get full access to this article
View all access options for this article.
References
1.
1. J. L. Rait, 1999, “Systemic effects of topical ophthalmic beta-adrenoceptor antagonists”, Aust.NZJ Ophthalmology, 27(1): 57–64.
2.
2. T. J. Zimmermann, 1993, “Topical ophthalmic beta blockers: a comparative review”, J. Ocul. Pharmacol., 9(4): 373–384.
3.
3. D. B. Berry, M. Y. Buskirk and M. B. Shields, 1984, “Betaxolol and timolol: a comparison of efficacy and side effects”, Arch. Ophthalmol., 102: 42-42.
4.
4. R. H. Stewart, R. L. Kimbrough and R. L. Ward, 1986, “Betaxolol vs Timolol: A six-month double-blind comparison”, Arch. Ophthalmol., 104: 46-46.
5.
5. R. Jani, O. Gan, Y. Ali, R. Rodstrom and S. Hancock, 1994, “Ion exchange resins for ophthalmic delivery”, J. Ocu. Pharmacol., 10(1): 57–67.
6.
6. V. H. L. Lee and J. R. Robinson, 1979, “Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits”, J. Pharm. Sci., 68: 673–684.
7.
7. T. F. Patton and J. R. Robinson, 1976, “Quantitative precorneal disposition of topical applied pilocarpine nitrate in rabbit eyes”, J. Pharm. Sci., 65: 1295–1301.
8.
8. N. A. Peppas and J. J. Sahlin, 1996, “Hydrogels mucoadhesive and bioadhesive materials—A review”, Biomaterials, 17: 1553–1561.
9.
9. A. Ahuja, R. K. Khar and J. Ali, 1997, “Mucoadhesive drug delivery systems”, Drug Dev. Ind. Pharm., 23: 489–515.
10.
10. K. M. Tur and H. S. Chang, 1998, “Evaluation of possible mechanism(s) of bioadhesion”, Int. J. Pharm., 1: 61–74.
11.
11. H. Blanco Fuente and S. Anguianolgea, F. J. OteroEspinar and J. BlancoMendez, 1996, “In vitro bioadhesion of carbopol hydrogels”, Int. J. Pharm., 142: 169–174.
12.
12. D. S. Jones, A. D. Woolfson and A. F. Brown, 1997, “Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers”, Int. J. Pharm., 15: 223–233.
13.
13. I. Genta, B. Conti, P. Perugini, F. Pavanetto, A. Spadaro and G. Puglisi, 1997, “Bioadhesive microspheres for ophthalmic administration of acyclovir”, J. Pharm. Pharmaco., 49: 737–742.
14.
14. J. M. Gu, J. R. Robinson and S. H. S. Leung, 1988, “Binding of acrylic polymers to mucin/epithelial surface: structure property relationship”, Crit. Rev. Therap. Drug Carrier Sys., 5: 21–67.
15.
15. H. Park and J. R. Robinson, 1987, “Mechanism of mucoadhesion of poly(acrylic acid) hydrogels”, Pharm. Res., 4: 457-457.
16.
16. F. Thermes, J. Grove, A. Rozier, B. Plazonnet, A. Constancis, C. Bunel and J. P. Vairon, 1992, “Mucoadhesion of copolymers and mixtures containing polyacrylic acid”, Pharm. Res., 9: 1563–1567.
17.
17. A. H. Shojaei and X. L. Li, 1997, “Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate”, J. Contr. Rel., 47: 151–161.
18.
18. R. Gurny, H. Ibrahim, A. Aebi, P. Buri, C. G. Wilson, N. Washington, P. Edman and O. Camber, 1987, “Design and evaluation of controlled release systems for the eye”, J. Contr. Rel., 6: 367–373.
19.
19. M. F. Saetone, P. Chetoni, M. T. Torracca, S. Burgalassi and B. Giannaccini, 1989, “Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid”, Int. J. Pharm., 51: 203–212.
20.
20. A. M. Durrani, S. J. Farr and I. W. Kellaway, 1994, “Precorneal clearance of mucoadhesive microspheres from the rabbit eye”, J. Pharm. Pharmco., 47: 581–584.
21.
21. C. M. Lehr, Y. H. Lee and V. H. Lee, 1994, “Improved ocular penetration of gentaminin by mucoadhesive polymer polycarbophil in the pigmented rabbit”, Invest. Ophthalmol. Vis. Sci., 1994, 35: 2809–2814.
22.
22. T. K. De and A. S. Hoffman, 1999, “A reverse microemulsion polymerization method for preparation of bioadhesive poly(acrylic acid)nanoparticles for mucosal drug delivery: Loading and release of timolol maleate”, Artif. Cells Blood Subs. Immob. Biotech., (accepted for publication), 2000.
23.
23. H. H. Clint, I. R. Collins, J. A. Williams, B. H. Robinson, T. F. Towey, P. Cajean and A. Khan-Lodhi, 1993, “Synthesis and characterisation of colloidal metal and semiconductor particles prepared in microemulsions”, Faraday Discuss., 95–219.
